Ke Y - Search Results

1

Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores.

Yang W, Wong Y, Ng OT, Bai LP, Kwong DW, Ke Y, Jiang ZH, Li HW, Yung KK, Wong MS. Yang W, et al. Among authors: ke y. Angew Chem Int Ed Engl. 2012 Feb 20;51(8):1804-10. doi: 10.1002/anie.201104150. Epub 2011 Nov 15. Angew Chem Int Ed Engl. 2012. PMID: 22086555 No abstract available.

2

Ceruloplasmin promotes iron uptake rather than release in BT325 cells.

Qian ZM, Tsoi YK, Ke Y, Wong MS. Qian ZM, et al. Among authors: ke y. Exp Brain Res. 2001 Oct;140(3):369-74. doi: 10.1007/s002210100831. Exp Brain Res. 2001. PMID: 11681312

3

Dual actions of brain-derived neurotrophic factor on GABAergic transmission in cerebellar Purkinje neurons.

Huang Y, Ko H, Cheung ZH, Yung KK, Yao T, Wang JJ, Morozov A, Ke Y, Ip NY, Yung WH. Huang Y, et al. Among authors: ke y. Exp Neurol. 2012 Feb;233(2):791-8. doi: 10.1016/j.expneurol.2011.11.043. Epub 2011 Dec 8. Exp Neurol. 2012. PMID: 22178325

4

Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex.

Li Q, Ke Y, Chan DC, Qian ZM, Yung KK, Ko H, Arbuthnott GW, Yung WH. Li Q, et al. Among authors: ke y. Neuron. 2012 Dec 6;76(5):1030-41. doi: 10.1016/j.neuron.2012.09.032. Neuron. 2012. PMID: 23217750 Free article.

5

Novel beta-amyloid aggregate inhibitors for Alzheimer's disease.

Wong RMS, Li HW, Kwong DWJ, Yung KKL, Ke Y. Wong RMS, et al. Among authors: ke y. Hong Kong Med J. 2019 Aug;25 Suppl 5(4):26-29. Hong Kong Med J. 2019. PMID: 31416983 Free article. No abstract available.

6

Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.

Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y. Huang XT, et al. Among authors: ke y. Neurobiol Aging. 2014 May;35(5):1045-54. doi: 10.1016/j.neurobiolaging.2013.11.004. Epub 2013 Nov 13. Neurobiol Aging. 2014. PMID: 24332448

7

Iron misregulation in the brain: a primary cause of neurodegenerative disorders.

Ke Y, Ming Qian Z. Ke Y, et al. Lancet Neurol. 2003 Apr;2(4):246-53. doi: 10.1016/s1474-4422(03)00353-3. Lancet Neurol. 2003. PMID: 12849213 Review.

8

Therapeutic effect of a histone demethylase inhibitor in Parkinson's disease.

Mu MD, Qian ZM, Yang SX, Rong KL, Yung WH, Ke Y. Mu MD, et al. Among authors: ke y. Cell Death Dis. 2020 Oct 28;11(10):927. doi: 10.1038/s41419-020-03105-5. Cell Death Dis. 2020. PMID: 33116116 Free PMC article.

9

Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson's Disease Biomarkers.

Li R, Li Y, Mu M, Yang B, Chen X, Lee WYW, Ke Y, Yung WH, Tang BZ, Bian L. Li R, et al. Among authors: ke y. ACS Appl Mater Interfaces. 2021 Mar 17;13(10):11609-11620. doi: 10.1021/acsami.0c22112. Epub 2021 Mar 8. ACS Appl Mater Interfaces. 2021. PMID: 33683858

10

Increased nitric oxide is one of the causes of changes of iron metabolism in strenuously exercised rats.

Qian ZM, Xiao DS, Ke Y, Liao QK. Qian ZM, et al. Among authors: ke y. Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R739-43. doi: 10.1152/ajpregu.2001.280.3.R739. Am J Physiol Regul Integr Comp Physiol. 2001. PMID: 11171652 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,292 results

Search Page

Filters